AJP - Regu Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 275: R1605-R1610, 1998;
0363-6119/98 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsuchida, T.
Right arrow Articles by Takei, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsuchida, T.
Right arrow Articles by Takei, Y.
Vol. 275, Issue 5, R1605-R1610, November 1998

Effects of homologous atrial natriuretic peptide on drinking and plasma ANG II level in eels

Takamasa Tsuchida and Yoshio Takei

Ocean Research Institute, The University of Tokyo, Minamidai, Nakano, Tokyo 164, Japan

    ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

The effects of eel atrial natriuretic peptide (ANP) on drinking were investigated in eels adapted to freshwater (FW) or seawater (SW) or in FW eels whose drinking was stimulated by a 2-ml hemorrhage. An intra-arterial infusion of ANP (0.3-3.0 pmol · kg-1 · min-1), which increased plasma ANP level 1.5- to 20-fold, inhibited drinking dose dependently in all groups of eels. The drinking rate recovered to the level before ANP infusion within 2 h after infusate was replaced by saline. The inhibition at 3.0 pmol · kg-1 · min-1 was profound in FW eels and hemorrhaged FW eels, whereas significant drinking still remained after inhibition in SW eels. Plasma ANG II concentration also decreased dose dependently during ANP infusion and recovered to the initial level after saline infusion in all groups of eels. The decrease at 3.0 pmol · kg-1 · min-1 was large in FW eels and hemorrhaged FW eels compared with that of SW eels. Thus the changes in drinking rate and plasma ANG II level were parallel during ANP infusion. Plasma sodium concentration and osmolality decreased during ANP infusion in SW and FW eels, and they were restored after saline infusion. In hemorrhaged FW eels, however, ANP infusion did not alter plasma sodium concentration and osmolality. Hematocrit did not change during ANP infusion in any group of eels. Collectively, ANP infusion at physiological doses decreased drinking rate and plasma ANG II concentration in parallel in both FW and SW eels. It remains undetermined whether the inhibition of drinking is caused by direct action of ANP or through inhibition of ANG II, which is known as a potent dipsogen in all vertebrate species, including eels.

water intake; Anguilla japonica

    INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

THE REGULATION OF DRINKING is one of the essential osmoregulatory processes for euryhaline teleosts such as eels, which migrate between freshwater (FW) and seawater (SW) (6). In FW, they are continually faced with the need to dispose of water that enters through the body surface, and so they usually drink little water. In SW, however, they drink copious amounts of water to compensate for the loss from the body surface due to the high environmental osmotic pressure (11, 13, 25). Thus the regulation of drinking is a key process that enables euryhaline fish to survive in both FW and SW.

Atrial natriuretic peptide (ANP) is a cardiac hormone known to be involved in volume and pressure homeostasis (3, 33). In mammals, ANP is secreted in response to an increase in blood volume and it acts to decrease blood volume to normal, suggesting that ANP is a volume-regulating hormone (28). In eels, however, ANP secretion is stimulated by an increase in plasma osmolality and ANP acts to excrete sodium ions specifically, thereby promoting SW adaptation (16, 36). Concerning the intake, ANP inhibits thirst and sodium appetite in mammals (2, 41). In fish, ANP and ventricular natriuretic peptide inhibit drinking in FW eels when injected at doses that are mildly hypotensive (34). Although ANP is an SW-adapting hormone in eels (33), its effect on drinking has not been examined in SW fish.

In contrast to ANP, ANG II is a potent dipsogen in all vertebrate species examined thus far (14, 21, 22). Interaction of ANP and ANG II occurs in regulation of thirst and sodium appetite in mammals (43), as observed in regulation of aldosterone secretion (23). ANG II is a potent dipsogen also in the eel (35), but the interaction with ANP has not been examined yet.

In the present study, the effect of eel ANP on drinking was examined in both FW and SW eels by slow infusion of the hormone at doses that were shown to be nondepressor in our previous study (36). Changes in plasma ANG II concentration were measured during ANP infusion to assess the interaction of ANP and ANG II in the regulation of drinking. Because drinking is vulnerable to changes in blood volume in eels (11), the change was minimized by adjusting the volume of infusion and blood sampling. The changes in plasma sodium concentration and osmolality were also examined, because these are important regulators of drinking, especially in terrestrial animals (7).

    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Animals. Cultured Japanese eels, Anguilla japonica, were purchased from a local dealer. They were kept in a 1-ton FW tank for >1 wk before use (FW-adapted eels). Some eels were transferred to a 0.5-ton SW tank and acclimated there for >2 wk before use (SW-adapted eels). Water in the tank was continuously filtered, aerated, and thermoregulated at 18 ± 0.5°C. Eels were not fed after purchase. They weighed 181.5 ± 2.8 g (mean ± SE, n = 24) at the time of experiment.

Surgical procedures. Eels were anesthetized in 0.1% (wt/vol) tricaine methanesulfonate (Sigma, St. Louis, MO) neutralized with sodium bicarbonate for 10 min. Then vinyl tubes (1.5 mm OD) were inserted into the esophagus and stomach of eels as described previously (39). The esophageal catheter was used for measurements of drinking rate, and the stomach catheter was used for reintroduction of drunk water. In addition, polyethylene tubes (0.8 mm OD) were inserted into the dorsal and ventral aorta for infusion of drugs and blood collection, respectively. The eels that bled >0.05 ml (0.7% of blood volume) during surgery were excluded from the experiment.

After surgery, eels were transferred to a plastic trough through which aerated and thermoregulated (18°C) water constantly circulated (Fig. 1). The catheter placed in the esophagus was connected to a drop counter for continuous measurement of drinking rate. The drunk water that dropped from the esophageal catheter (0.03 ml/drop) was reintroduced into the stomach with FW (for FW-adapted fish) or 80% SW (for SW-adapted fish) by means of a pulse injector synchronized with the drop counter (39). Eighty-percent SW was used for SW fish because drunk SW that dropped from the esophageal catheter was diluted to 78.7 ± 0.02% (n = 4) because of desalting by the esophagus (13). The catheters in the aortas were connected to plastic syringes filled with 0.9% NaCl solution. The syringe connected to the dorsal aorta was set in the infusion pump for ANP infusion (Fig. 1). Eels were allowed to recover for >18 h postoperatively.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 1.   Experimental setup for continuous measurement of drinking rate in an esophagus- and stomach-cannulated eel. Each drop of drunk water was reintroduced into the stomach by a pulse injector synchronized with a drop counter. Catheters in dorsal and ventral aortas were used for ANP infusion and blood sampling, respectively.

Experimental protocol. Three groups of eels were used in this experiment: 1) FW-adapted eels, 2) FW eels subjected to 2 ml of hemorrhage (28.6% blood volume) on the previous day, and 3) SW-adapted eels. The second group was prepared because drinking rate of FW eels was too low to demonstrate clear inhibition, and because hypovolemia is a potent stimulus for drinking in the eel (11). The eels received hourly infusions of isotonic saline followed by increasing doses of eel ANP (Peptide Institute, Osaka, Japan) at 0.3, 1.0, and 3.0 pmol · kg-1 · min-1 and ended with saline infusion for 2 h. Infusion rate was 0.3 ml/h, whereas 0.6 ml of blood was sampled every hour from the ventral aorta into the chilled plastic syringe containing 10% 2K-EDTA (10 µl/ml blood). Fifty microliters of collected blood were transferred into a capillary for measurements of hematocrit and plasma sodium concentration and osmolality. After centrifugation of the blood sample, plasma was used for measurements of eel ANP and ANG II by radioimmunoassay. The blood cells were washed two times with 1 ml 0.9% saline, reconstituted with 0.3 ml of saline, and injected into the circulation within 5 min after blood sampling. Each drop from the esophageal catheter was monitored as a spike in the recorder, and water intake every 10 min was stored in the memory of the drop counter (Fig. 1). The details of the drop counter and pulse injector system have been described elsewhere (39).

Eel ANP concentration was determined by homologous radioimmunoassay (32). Eel ANG II concentration was measured by radioimmunoassay for mammalian [Asp1,Ile5] ANG II (42). The antibody used in this assay exhibited 75% cross-reactivity with eel [Asn1,Val5] ANG II (Fig. 2). 125I-labeled [Asn1,Val5] ANG II was prepared by a lactoperoxidase method and isolated by reverse-phase HPLC (ODS-120T column, 0.46 × 25 cm; Tosoh, Tokyo, Japan) with a linear gradient of CH3CN from 15 to 60% for 60 min as used for iodination of eel ANP (32). The HPLC completely separated monoiodinated ANG II from unlabeled and diiodinated ANG II. The dilution curve of immunoreactive ANG II in eel plasma was parallel to the standard curve of eel ANG II (Fig. 2). ANG II concentration was measured directly with 40 µl of eel plasma, because recovery of synthetic eel ANG II added to the plasma was 93.2 ± 7.8% (n = 4) and because the values of direct measurement and after extraction of acidic acetone (27) do not differ (95.5 ± 4.7%, n = 4). Furthermore, reverse-phase HPLC of extracted eel plasma revealed that the immunoreactive ANG II was detected only at the elution position identical to [Asn1,Val5] ANG II (data not shown). The intra-assay and interassay coefficients of variation were 5.8 and 14.0%, respectively.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 2.   Standard curve for radioimmunoassay of eel [Asn1,Val5] ANG II (black-triangle) using 125I-labeled eel ANG II. Displacement curve of human [Asp1,Ile5] ANG II (bullet ), against which antiserum was originally raised, was also given. Serial dilution curve of eel plasma (black-diamond ) was parallel with standard curve of eel ANG II.

The sodium concentration in plasma was determined in an atomic absorption spectrophotometer (Hitachi 180-50, Tokyo, Japan), and plasma osmolality was determined in a vapor pressure osmometer (Wescor 5500, Logan, UT). All determinations were made in duplicate or triplicate.

Analysis of data. Student's t-test was applied for comparison of different groups of eels. A paired t-test or Fisher's exact probability test was used for analysis of time course data. Significance was set at P < 0.05. All results are expressed as means ± SE.

    RESULTS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Plasma ANP concentration. Plasma ANP concentration increased dose dependently during ANP infusion in all groups of eels (Table 1). After infusate was changed back to saline, plasma ANP level was still high for 1 h but fell to the initial level in 2 h.

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Changes in plasma ANP concentration (fmol/ml) during eel ANP infusion in FW, HFW, and SW eels

Changes in drinking rate. Drinking rate was very low in FW eels; however, ANP infusion decreased it to zero (Fig. 3A). The drinking rate recovered gradually during saline infusion, and it rebounded above the initial level after 2 h. The dose-dependent inhibition was more apparent in hemorrhaged FW eels, which exhibited greater initial drinking, and eels drank practically no water at 3.0 pmol · kg-1 · min-1 (Fig. 3B). ANP also inhibited copious drinking of SW eels in a dose-dependent manner (Fig. 3C). However, the inhibition was small, so that SW eels drank more water than FW eels and hemorrhaged FW eels at 3.0 pmol · kg-1 · min-1. The inhibition disappeared after saline infusion also in SW eels.


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 3.   Effects of eel atrial natriuretic peptide (ANP) infusion (0.3-3.0 pmol · kg-1 · min-1) on drinking rate in freshwater (FW) eels (n = 8; A), hemorrhaged FW eels (n = 8; B), and seawater (SW) eels (n = 8; C). Values are shown as means ± SE. * P < 0.05 from initial value by paired t-test.

Changes in plasma ANG II level. Plasma ANG II concentration decreased dose dependently during ANP infusion, and it was restored to the initial level after infusate was replaced by saline in all groups of eels (Fig. 4). However, the percentage of decrease was much smaller in SW eels compared with that of FW eels and hemorrhaged FW eels.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 4.   Effects of eel ANP infusion (0.3-3.0 pmol · kg-1 · min-1) on plasma ANG II concentration in FW eels (n = 8; A), hemorrhaged FW eels (n = 8; B), and SW eels (n = 8; C). Values are shown as means ± SE. * P < 0.05 from initial value by paired t-test.

Plasma sodium concentration, osmolality, and hematocrit. Plasma sodium concentration and osmolality were higher in SW eels than in FW eels and hemorrhaged FW eels (Fig. 5). Plasma sodium concentration and osmolality decreased dose dependently in both FW and SW eels during the ANP infusion, and the levels were restored gradually after saline infusion. However, there were no changes in plasma sodium concentration and osmolality in hemorrhaged FW eels. Hematocrit did not change during ANP infusion in all groups.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 5.   Changes in plasma sodium concentration (A), plasma osmolality (B), and hematocrit (C) during eel ANP infusion in FW eels (bullet ), hemorrhaged FW eels (open circle ), and SW eels (). Data are shown as means ± SE. * P < 0.05 from initial value by paired t-test.

    DISCUSSION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

The present study showed that eel ANP potently inhibits water intake and plasma ANG II concentration in a dose-dependent manner in both FW and SW eels. The plasma ANP concentration produced by infusion of 0.3 or 1.0 pmol · kg-1 · min-1 was within the upper limit of individual and seasonal variation of intact fishes (16). The ANP level after infusion of 3.0 pmol · kg-1 · min-1 was high, but it was also observed endogenously after injection of hypertonic saline into FW eels (18). Therefore, eels are highly sensitive to ANP for inhibition of drinking and renin secretion. We reported previously that infusion of ANP even at 3.0 pmol · kg-1 · min-1 did not change arterial blood pressure in both FW and SW eels (36). Therefore, the effects on drinking and renin secretion are more sensitive to ANP than is the vascular effect in the eel. Furthermore, because blood pressure and blood volume, which profoundly influence drinking and renin secretion (11, 12, 26), were maintained constant in this study, the ANP effects may be caused by its direct action.

In mammals, ANP has been shown to inhibit drinking and sodium appetite when administered into the cerebral ventricles (2, 41). However, the inhibition was observed only in animals whose appetite was stimulated by dehydration or ANG II injection. In contrast, the inhibition was observed even in intact eels in the present study. These results support the notion that eels are highly sensitive to the antidipsogenic effect of ANP. Furthermore, the antidipsogenic effect of ANP is more potent than the dipsogenic effect of ANG II in the eel (33), although the reverse is true in mammals (43).

Cellular dehydration, extracellular dehydration, and ANG II are major dipsogenic stimuli in birds and mammals (7, 20, 37). Hypovolemia and ANG II also stimulate drinking in the eel (11), but cellular dehydration caused by injection of hypertonic saline suppresses drinking in both FW and SW eels despite a concomitant increase in plasma ANG II level (38). Because ANP is a powerful antidipsogen in the eel, as shown in this study, and because hypernatremia profoundly augments ANP secretion in the eel (18), the unexpected inhibition of drinking after injection of hypertonic saline in the eel may be due to increased plasma ANP. An unexpected hypotension observed after injection of hypertonic saline in the eel may also be due to increased plasma ANP (30).

ANP is secreted in response to an increase in blood volume, and the increased ANP decreases blood volume by inhibiting the intake and stimulating the excretion of water and sodium (3, 28). In contrast, renin is released in response to hypovolemia and ANG II stimulates the intake and inhibits the excretion of water and sodium (20). Therefore, the renin-angiotensin system antagonizes the natriuretic peptide system in every aspect of osmoregulation. ANP inhibits renin secretion both in vivo and in vitro in selected species of mammals (4, 10), but the effect is still controversial, especially in vivo, because it decreases blood pressure (19, 29). In the present study, low doses of ANP decreased plasma ANG II concentration in vivo without changing blood pressure and blood volume. In the eel, therefore, ANP appears to be highly potent for inhibiting renin secretion by direct actions.

The present study showed that the inhibition of drinking by ANP is accompanied by a parallel decrease in plasma ANG II concentration in both FW and SW eels. Furthermore, the percentage inhibition of drinking and plasma ANG II level was similar in both FW and SW eels. Therefore, it is possible that the inhibition of drinking by ANP is mediated by a decrease in plasma ANG II. In fact, ANG II is a potent dipsogen in the eel (35) and other vertebrate species (21, 22). However, the interaction of ANP and ANG II in regulation of drinking in the eel remains to be determined.

Plasma sodium concentration and osmolality decreased in FW and SW eels but not in hemorrhaged FW eels during ANP infusion. In hemorrhaged eels, sodium-retaining mechanisms may have been maximally activated. This result, together with those reported previously (5, 34), indicates that ANP is a sodium-extruding hormone that promotes SW adaptation. In SW, however, fish have to drink SW and absorb water by the gut to cope with dehydration (6), but ANP inhibits drinking and subsequent intestinal absorption of water in SW eels (1, 24). After transfer of eels to SW, reflex drinking occurs immediately in response to chloride ions in SW (11) but the drinking rate decreases transiently for 1-2 h and increases again gradually thereafter (38). The plasma ANP level increases for 1-2 h after exposure to SW and gradually decreases to the FW level (17). Therefore, plasma ANP level does not differ between FW and SW eels, as shown in this study. Comparing the changes in drinking rate and plasma ANP level, it seems that ANP is involved in the temporary inhibition of drinking for 1-2 h after exposure to SW. Because active desalting of drunk SW occurs by the esophagus, the eels most likely suffer from severe hypernatremia if the initial burst of drinking continues after SW exposure. It seems, therefore, that the transient depression of drinking for 1-2 h after SW exposure may be beneficial to counteract the excess hypernatremia during the initial phase of SW adaptation.

Perspectives

The present study shows that ANP decreases drinking rate and plasma ANG II level (probably renin secretion) in the eel at doses that do not affect blood pressure. This is rather surprising because, in mammals, vascular effect usually overrides the other effects and ANP knockout mice exhibit normal drinking and plasma ANG II but lower blood pressure compared with normal mice (15). Therefore, the eel may serve as a good model to analyze how ANP is involved in the mechanisms regulating drinking and renin secretion.

Another important aspect for future studies is whether ANP acts directly on the brain to inhibit drinking or the inhibition is mediated by depressed plasma ANG II. ANP is known to act on the brain to inhibit drinking in mammals (2, 43), but aquatic fish can stop and start drinking only by constriction and relaxation of the esophageal sphincter. Because direct application of ANG II into the cerebral ventricles of eels shows its action on the brain (31), a similar technique can be used for ANP to clarify its site of action. The mediation of ANG II in ANP action can be examined by infusing ANP with ANG II to maintain normal plasma ANG II level during ANP infusion or by using various inhibitors of the renin-angiotensin system. In A. anguilla, a bolus injection of ANG I-converting enzyme inhibitor depresses drinking in SW fish but not in FW fish (40). Thus ANG II does not seem to be involved in normal drinking in FW eels.

    ACKNOWLEDGEMENTS

We are grateful to Dr. H. Nishimura of the University of Tennessee, Memphis, for critical reading of this manuscript and to Dr. K. Yamaguchi of Niigata University for supplying us with ANG II antiserum.

    FOOTNOTES

This investigation was supported in part by a grant from the Ministry of Education, Science and Culture, Japan (09102008) to Y. Takei.

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.

Address for reprint requests: T. Tsuchida, Laboratory of Physiology, Ocean Research Institute, The Univ. of Tokyo, 1-15-1 Minamidai, Nakano, Tokyo 164-8639, Japan.

Received 9 March 1998; accepted in final form 28 July 1998.

    REFERENCES
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

1.   Ando, M., K. Kondo, and Y. Takei. Effects of eel atrial natriuretic peptide on NaCl and water transport across the intestine of the seawater eel. J. Comp. Physiol. [B] 162: 436-439, 1992[Medline].

2.   Antunes-Rodrigues, J., S. M. McCann, L. C. Rogers, and W. K. Samson. Atrial natriuretic factor inhibits dehydration- and angiotensin II-induced water intake in the conscious, unrestrained rat. Proc. Natl. Acad. Sci. USA 82: 8720-8723, 1985[Abstract/Free Full Text].

3.   Brenner, B. M., B. J. Ballerman, M. E. Gunning, and M. L. Zeidel. Diverse biological actions of atrial natriuretic peptide. Physiol. Rev. 70: 665-699, 1990[Free Full Text].

4.   Ehmke, H., P. B. Persson, A. Just, B. Nafz, M. Seyfarth, E. Hackenthal, and H. R. Kirchheim. Physiological concentrations of ANP exert a dual regulatory influence on renin release in conscious dogs. Am. J. Physiol. 263 (Regulatory Integrative Comp. Physiol. 32): R529-R536, 1992[Abstract/Free Full Text].

5.   Evans, D. H. An emerging role for a cardiac peptide hormone in fish osmoregulation. Annu. Rev. Physiol. 52: 43-60, 1990[Medline].

6.   Evans, D. H. Osmotic and ionic regulation. In: The Physiology of Fishes, edited by D. H. Evans. Boca Raton, FL: CRC, 1993, p. 315-342.

7.   Fitzsimons, J. T. The Physiology of Thirst and Sodium Appetite. Cambridge, UK: Cambridge Univ. Press, 1979.

8.   Fitzsimons, J. T., and S. Kaufman. Cellular and extracellular dehydration and angiotensin as stimuli to drinking in the common iguana, Iguana iguana. J. Physiol. (Lond.) 265: 443-463, 1977[Abstract/Free Full Text].

9.   Hackenthal, E., M. Paul, D. Ganten, and R. Taugner. Morphology, physiology, and molecular biology of renin secretion. Physiol. Rev. 70: 1067-1116, 1990[Free Full Text].

10.   Henrich, W. L., E. A. McAllister, P. B. Smith, and W. B. Campbell. Guanosine 3',5'-cyclic monophosphate as a mediator of inhibition of renin release. Am. J. Physiol. 255 (Renal Fluid Electrolyte Physiol. 24): F474-F478, 1988[Abstract/Free Full Text].

11.   Hirano, T. Some factors regulating water intake by the eel, Anguilla japonica. J. Exp. Biol. 61: 737-747, 1974[Abstract/Free Full Text].

12.   Hirano, T., and S. Hasegawa. Effects of angiotensins and other vasoactive substances on drinking in the eel, Anguilla japonica. Zool. Sci. 1: 106-113, 1984.

13.   Hirano, T., and N. Mayer-Gostan. Eel esophagus as an osmoregulatory organ. Proc. Natl. Acad. Sci. USA 73: 1348-1350, 1976[Abstract/Free Full Text].

14.   Hoff, K. S., and S. D. Hillyard. Angiotensin II stimulates cutaneous drinking in the toad, Bufo punctatus. Physiol. Zool. 64: 1165-1172, 1991.

15.   John, S. W. M., J. H. Krege, P. M. Hagaman, J. B. Hodjin, S. C. Pang, T. G. Flynn, and O. Smithies. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 267: 679-681, 1995[Abstract/Free Full Text].

16.   Kaiya, H., and Y. Takei. Atrial and ventricular natriuretic peptide concentrations in plasma of freshwater- and seawater-adapted eels. Gen. Comp. Endocrinol. 102: 183-190, 1996[Medline].

17.   Kaiya, H., and Y. Takei. Changes in plasma atrial and ventricular natriuretic peptide concentrations after transfer of eels from fresh water to seawater or vice versa. Gen. Comp. Endocrinol. 104: 337-345, 1996[Medline].

18.   Kaiya, H., and Y. Takei. Osmotic and volaemic regulation of atrial and ventricular natriuretic peptide secretion in conscious eels. J. Endocrinol. 149: 441-447, 1996[Abstract/Free Full Text].

19.   Kivlighn, S. D., T. E. Lohmeier, H. M. Yang, and Y. Shin. Chronic effects of a physiological dose of ANP on arterial pressure and renin release. Am. J. Physiol. 258 (Heart Circ. Physiol. 27): H1491-H1497, 1990[Abstract/Free Full Text].

20.   Kobayashi, H., and Y. Takei. The Renin-Angiotensin System: Comparative Aspects. Berlin, Germany: Springer, 1996.

21.   Kobayashi, H., H. Uemura, Y. Takei, N. Itazu, M. Ozawa, and K. Ichinohe. Drinking induced by angiotensin II in fishes. Gen. Comp. Endocrinol. 49: 295-306, 1983[Medline].

22.   Kobayashi, H., H. Uemura, M. Wada, and Y. Takei. Ecological adaptation of angiotensin-induced drinking in tetrapods. Gen. Comp. Endocrinol. 38: 93-104, 1979[Medline].

23.   Kuhlen, R., H. Seibt, R. Engel, and G. Kaczmarczyk. Interactions of physiological and pharmacological concentrations of ANP and angiotensin II in conscious dogs. Am. J. Physiol. 263 (Regulatory Integrative Comp. Physiol. 32): R537-R543, 1992[Abstract/Free Full Text].

24.   Loretz, C. A., and Y. Takei. Natriuretic peptide inhibition of intestinal salt absorption in the Japanese eel: physiological significance. Fish Physiol. Biochem. 17: 319-324, 1997.

25.   Maetz, J., and E. Skadhauge. Drinking rates and gill ionic turnover in relation to external salinities in the eel. Nature 217: 371-373, 1968[Medline].

26.   Nishimura, H., L. G. Lunde, and A. Zucker. Renin response to hemorrhage and hypotension in the aglomerular toadfish Opsanus tau. Am. J. Physiol. 237 (Heart Circ. Physiol. 6): H105-H111, 1979.

27.   Phillips, M. I., B. Kimura, and M. K. Raizada. Measurement of brain peptides: angiotensin and atrial natriuretic peptide in tissue and cell culture. In: Methods in Neurosciences. Neuropeptide Technology: Synthesis, Assay, Purification, and Processing, edited by P. M. Conn. London: Academic, 1991, vol. 6, p. 177-206.

28.   Ruskoaho, H. Atrial natriuretic peptide: synthesis, release and metabolism. Pharmacol. Rev. 44: 479-601, 1992[Medline].

29.   Tagaki, M., M. Takagi, R. Franco-Saenz, and P. J. Murlow. Effect of atrial natriuretic peptide on renin release in a superfusion system of kidney slices and dispersed juxtaglomerular cells. Endocrinology 122: 1437-1442, 1988[Abstract/Free Full Text].

30.   Takei, Y. Changes in blood volume after alteration of hydromineral balance in conscious eels, Anguilla japonica. Comp. Biochem. Physiol. A Physiol. 91A: 293-297, 1988.

31.   Takei, Y. Vasoactive hormones and body fluid homeostasis: a phylogenetic consideration. In: Phylogenetic Models in Functional Coupling of the CNS and the Cardiovascular System. Comparative Physiology, edited by K. Kuwasawa, R. B. Hill, R. B. McMahon, and T. Kuramoto. Basel, Switzerland: Karger, 1992, vol. 11, p. 239-249.

32.   Takei, Y., K. Ando, and M. Kawakami. Atrial natriuretic peptide in eel plasma, heart and brain characterized by homologous radioimmunoassay. J. Endocrinol. 135: 325-331, 1992[Abstract/Free Full Text].

33.   Takei, Y., and R. J. Balment. Natriuretic factors in nonmammalian vertebrates. In: New Insights in Vertebrate Kidney Function, edited by J. A. Brown, R. J. Balment, and J. C. Rankin. Cambridge, UK: Cambridge Univ. Press, 1993, p. 351-385.

34.   Takei, Y., and R. J. Balment. Biochemistry and physiology of a family of eel natriuretic peptides. Fish Physiol. Biochem. 11: 1-6, 1993.

35.   Takei, Y., T. Hirano, and H. Kobayashi. Angiotensin and water intake on the Japanese eel, Anguilla japonica. Gen. Comp. Endocrinol. 38: 466-475, 1979[Medline].

36.   Takei, Y., and H. Kaiya. Antidiuretic effect of eel ANP infused at physiological doses in conscious, seawater-adapted eels, Anguilla japonica. Zool. Sci. 15: 399-404, 1998[Medline].

37.   Takei, Y., Y. Okawara, and H. Kobayashi. Control of drinking in birds. In: Progress in Avian Osmoregulation, edited by M. R. Hughes, and A. Chadwick. Leeds, UK: Leeds Philosophical and Literary Society, 1989, p. 1-12.

38.   Takei, Y., J. Okubo, and K. Yamaguchi. Effects of cellular dehydration on drinking and plasma angiotensin II level in the eel, Anguilla japonica. Zool. Sci. 5: 43-51, 1988.

39.  Takei, Y., T. Tsuchida., and A. Tanakadate. Evaluation of water intake in seawater adaptation in eels using a synchronized drop counter and pulse injector system. Zool. Sci. In press.

40.   Tierney, M. L., G. Luke, G. Cramb, and N. Hazon. The role of the renin-angiotensin system in the control of blood pressure and drinking in the European eel, Anguilla anguilla. Gen. Comp. Endocrinol. 100: 39-48, 1995[Medline].

41.   Weisinger, R. S., J. R. Blair-West, D. A. Denton, and E. Tarjan. Central administration of atrial natriuretic peptide suppresses sodium and water intake of sheep. Brain Res. 579: 113-118, 1992[Medline].

42.   Yamaguchi, K. Effects of water deprivation on immunoreactive angiotensin II levels in plasma, cerebroventricular perfusate and hypothalamus of the rat. Acta Endocrinol. 97: 137-144, 1981.

43.   Zhu, B., and J. Herbert. Central antagonism of atrial natriuretic peptides on behavioral and hormonal responses to angiotensin II: mapping with c-fos. Brain Res. 734: 55-60, 1996[Medline].


Am J Physiol Regul Integr Compar Physiol 275(5):R1605-R1610
0002-9513/98 $5.00 Copyright © 1998 the American Physiological Society



This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. R. Johnson and K. R. Olson
Responses of the trout cardiac natriuretic peptide system to manipulation of salt and water balance
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2009; 296(4): R1170 - R1179.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Ogoshi, S. Nobata, and Y. Takei
Potent osmoregulatory actions of homologous adrenomedullins administered peripherally and centrally in eels
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2008; 295(6): R2075 - R2083.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Biol.Home page
W. G. Anderson, Y. Takei, and N. Hazon
Osmotic and volaemic effects on drinking rate in elasmobranch fish
J. Exp. Biol., April 15, 2002; 205(8): 1115 - 1122.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
Y. Takei and S. Hirose
The natriuretic peptide system in eels: a key endocrine system for euryhalinity?
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2002; 282(4): R940 - R951.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
Y. Takei, T. Tsuchida, Z. Li, and J. M. Conlon
Antidipsogenic effects of eel bradykinins in the eel Anguilla japonica
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2001; 281(4): R1090 - R1096.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
Y. Takei and T. Tsuchida
Role of the renin-angiotensin system in drinking of seawater-adapted eels Anguilla japonica: a reevaluation
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2000; 279(3): R1105 - R1111.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsuchida, T.
Right arrow Articles by Takei, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsuchida, T.
Right arrow Articles by Takei, Y.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online